Is RXO (RXO) Stock Stretched Or Still Reasonable At 52 Week High?

RXO, Inc. Common Stock

RXO, Inc. Common Stock

RXO

0.00

RXO stock has delivered a sharp 114.9% gain year to date, yet the valuation picture is split, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to meaningful upside while market multiples suggest the shares already trade at a premium.

  • The 114.9% year to date return has shifted RXO from a relatively under the radar stock into one where valuation discipline matters more for any new capital.
  • Recent optimism around RXO's outlook and analyst upgrades can support higher cash flow expectations, but concerns over sales volumes, returns on capital and a short cash runway may limit how much investors are willing to pay for that growth story.
  • RXO scores 4 out of 6 on the value checks, which points to a mixed picture rather than a clear bargain or clear overvaluation on the broader assessment.

The issue now is whether RXO's current price already reflects the upside implied by the intrinsic value estimate, or if there is still a margin of safety after such a strong run.

Does RXO Look Undervalued on Cash Flow?

The Discounted Cash Flow (DCF) approach estimates what RXO is worth today based on the cash it is expected to generate in the future.

RXO currently reports latest twelve month free cash flow of about $21.8 million outflow, so the model assumes cash flows recover into positive territory and then grow over time rather than staying at current levels. Using those assumptions, the 2 Stage Free Cash Flow to Equity model produces an intrinsic value estimate of about $49.47 per share in dollar terms.

Compared with the current share price, which is close to the recent $29.74 high, the DCF output suggests RXO appears roughly 44.2% undervalued. RXO stock reaching a 52 week high while analyst views remain mixed may help explain why the market price is still below the value implied by this cash flow model.

Overall, the DCF analysis indicates RXO stock appears undervalued at current levels.

Our Discounted Cash Flow (DCF) analysis suggests RXO is undervalued by 44.2%. Track this in your watchlist or portfolio, or discover 43 more high quality undervalued stocks.

RXO Discounted Cash Flow as at Jul 2026
RXO Discounted Cash Flow as at Jul 2026

Is RXO Getting Expensive on Sales?

P/S is a useful cross check for RXO because the business is still working through losses, so revenue based metrics can sometimes be more stable than earnings based ones. On this measure, RXO trades on a P/S of about 0.8x, which is below both the Transportation industry average of 1.2x and the peer group average of 1.8x.

However, the tailored fair P/S ratio for RXO is lower still at roughly 0.7x, once factors such as its margins, growth profile, size and risk are taken into account. That indicates that the current 0.8x multiple sits above what the model views as a reasonable level, even if it looks modest next to broader sector benchmarks.

On balance, RXO stock appears overvalued on the P/S multiple when compared with its modelled fair ratio.

NYSE:RXO P/S Ratio as at Jul 2026
NYSE:RXO P/S Ratio as at Jul 2026

The RXO Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for RXO pick up where the mixed DCF and P/S results leave off by spelling out which paths for RXO's revenue, margins and earnings would need to play out for the stock to be worth materially more or less than today's price on the Community page. Instead of a single ratio or model output, they describe the future that number relies on so you can watch whether RXO's actual progress lines up with that story.

One of the top community narratives on RXO: 28% overvalued

"RXO's relentless investment in AI powered, proprietary digital freight matching technology is rapidly boosting employee productivity and driving operating leverage..."

Do you think there's more to the story for RXO? Head over to our Community to see what others are saying!

The Bottom Line

RXO sits in a tension between the Discounted Cash Flow (DCF) view, which points to meaningful intrinsic value upside, and a market multiple view that already prices the stock as overvalued on sales. With broader valuation checks landing in mixed territory, neither signal clearly dominates. What really decides it from here is whether RXO can turn its current business profile into stronger, more durable cash generation than the market currently assumes, rather than just sustaining a higher P/S multiple driven by sentiment.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.